BINKO Memo 120 mg film-coated tablets, 60 pcs

Instructions for use for BINKO Memo 120 mg film-coated tablets, 60 pcs

Detailed instructions for BINKO Memo 120 mg film-coated tablets, 60 pcs

Field of use

Binko Memo 120 mg film -coated tablets (pack size: 60 pc) with high -quality special extract from the proven medicinal plant in forgetfulness or lack of concentration. To improve age -related cognitive impairment and the quality of life in light dementia

Active ingredients / ingredients / ingredients

Binko Memo 120 mg film -coated tablets (pack size: 60 pc) contains the following active ingredient:

Ginko-Biloba leaf dry extract.

Compilation: 1 film-coated tablet contains 120 mg quantified, refined dry extract made of ginkgo biloba leaves (35–67: 1), moving out: Acetone 60 % (m/m). The extract is quantified to 22.0–27.0 % flavonoids, calculated as flavonol glycosides, 2.8–3.4 % ginkgolide a, b and c, 2.6–3.2 % bilobalide and contains a maximum of 5 ppm Ginkgolic acids.

Other components: tablet core: croscarmellose-na, high disp. Silicium dioxide, lactose monohydrate, magnesium stearate (Ph.Eur.) [pflanzl.], microcrist. Cellulose, spray-dried glucose syrup. Found: macrogol 3350, polyvinyl alcohol, talcum, titanium dioxide (E171), iron (III) hydroxide oxide x H2O (E172).

Contradictions

Binko Memo 120 mg film -coated tablets (pack size: 60 pc) should not be used in the case of hypersensitivity to one of the ingredients it contains.

dosage

Dosage recommendation of Binko Memo 120 mg film -coated tablets (pack size: 60 pc):

Adults from the year 18: 2x a day 1 film -coated tablet, in the morning and evening a film -coated tablet as a whole, take an unscurdered with liquid.

Taking

• The film -coated tablets are taken orally. Do not take the tablets on the back. The tablets should be swallowed as a whole (not chewed) with liquid, preferably with a glass of drinking water. The intake can take place independently of the meals.

Patient information

• Warnings and Precautions
  • Please speak to your doctor or pharmacist before taking the medicine:
    • if you have a pathologically increased tendency to bleed (hemorrhagic diathesis) and at the same time treatment with blood -thinning medication,
    • if you are known to an antiquity (epilepsy),
    • if an operation is planned in the next 3 to 4 days,
    • when you take Efavirenz.
  • Talk to your doctor or pharmacist if the symptoms deteriorate during treatment.
  • Children and adolescents
    • There is no relevant indication for children and adolescents.

 

• Wateriness and ability to operate machines
  • Your doctor will tell you whether your illness is allowed to drive you and operate machines.
  • There were no sufficient studies on the effects on the traffic and operating machines.

Pregnancy

• If you are pregnant or breastfeed, or if you suspect that you are pregnant or intend to become pregnant, ask your doctor or pharmacist for advice before taking this drug.
• Pregnancy
  • Since there are individual indications that ginkgo-containing preparations could increase willingness to bleednot being taken to pregnancy.
• Breastfeeding
  • This medicine should not be used during breastfeeding because there is no sufficient examinations. It is not known whether the ingredients of the extract change into breast milk.

Hints

Manufacturer:  Klinge Pharma GmbH, Bergfeldstraße 9, 83607 Holzkirchen